NTUS
Income statement / Annual
Last year (2021), Natus Medical Incorporated's total revenue was $473.44 M,
an increase of 13.89% from the previous year.
In 2021, Natus Medical Incorporated's net income was $13.18 M.
See Natus Medical Incorporated,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
FY-2012
|
| Period Ended |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
12/31/2012 |
| Operating Revenue |
$473.44 M |
$415.68 M |
$495.18 M |
$530.89 M |
$500.97 M |
$381.89 M |
$375.87 M |
$355.83 M |
$344.11 M |
$292.28 M |
| Cost of Revenue |
$199.76 M
|
$199.15 M
|
$203.47 M
|
$226.88 M
|
$219.76 M
|
$146.96 M
|
$148.33 M
|
$141.45 M
|
$142.08 M
|
$128.81 M
|
| Gross Profit |
$273.68 M
|
$216.53 M
|
$291.71 M
|
$304.02 M
|
$281.21 M
|
$234.93 M
|
$227.54 M
|
$214.39 M
|
$202.03 M
|
$163.47 M
|
| Gross Profit Ratio |
0.58
|
0.52
|
0.59
|
0.57
|
0.56
|
0.62
|
0.61
|
0.6
|
0.59
|
0.56
|
| Research and Development Expenses |
$56.31 M
|
$61.30 M
|
$58.73 M
|
$61.48 M
|
$51.82 M
|
$33.44 M
|
$30.43 M
|
$31.79 M
|
$32.07 M
|
$29.97 M
|
| General & Administrative Expenses |
$52.75 M
|
$49.11 M
|
$59.65 M
|
$68.70 M
|
$74.42 M
|
$50.88 M
|
$46.36 M
|
$49.28 M
|
$48.53 M
|
$50.96 M
|
| Selling & Marketing Expenses |
$116.01 M
|
$107.28 M
|
$129.11 M
|
$136.68 M
|
$126.17 M
|
$84.83 M
|
$87.68 M
|
$87.47 M
|
$87.15 M
|
$77.29 M
|
| Selling, General & Administrative Expenses |
$168.77 M
|
$156.40 M
|
$188.76 M
|
$205.38 M
|
$200.59 M
|
$135.71 M
|
$134.04 M
|
$136.75 M
|
$135.68 M
|
$128.25 M
|
| Other Expenses |
$17.13 M
|
$15.22 M
|
$15.14 M
|
$24.49 M
|
$19.17 M
|
$8.98 M
|
$7.45 M
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$242.20 M
|
$232.92 M
|
$262.64 M
|
$291.35 M
|
$271.58 M
|
$178.14 M
|
$171.92 M
|
$168.54 M
|
$167.75 M
|
$158.21 M
|
| Cost And Expenses |
$441.96 M
|
$432.07 M
|
$466.10 M
|
$518.22 M
|
$491.34 M
|
$325.10 M
|
$320.25 M
|
$309.98 M
|
$309.83 M
|
$287.03 M
|
| Interest Income |
$0.00
|
$11,000.00
|
$250,000.00
|
$334,000.00
|
$425,000.00
|
$315,000.00
|
$27,000.00
|
$119,000.00
|
$0.00
|
$56,000.00
|
| Interest Expense |
$1.87 M
|
$3.66 M
|
$4.94 M
|
$6.79 M
|
$5.08 M
|
$430,000.00
|
$352,000.00
|
$438,000.00
|
$1.68 M
|
$489,000.00
|
| Depreciation & Amortization |
$28.09 M
|
$28.12 M
|
$30.72 M
|
$33.86 M
|
$30.10 M
|
$16.88 M
|
$15.99 M
|
$11.76 M
|
$12.85 M
|
$12.62 M
|
| EBITDA |
$49.32 M |
$9.71 M |
$14.41 M |
$8.40 M |
$40.33 M |
$72.21 M |
$68.75 M |
$58.21 M |
$46.09 M |
$17.52 M |
| EBITDA Ratio |
0.1
|
0.02
|
0.03
|
0.02
|
0.08
|
0.19
|
0.18
|
0.16
|
0.13
|
0.06
|
| Operating Income Ratio |
0.04
|
-0.05
|
-0.03
|
-0.05
|
0.02
|
0.14
|
0.14
|
0.13
|
0.1
|
0.02
|
| Total Other Income/Expenses Net |
-$1.87 M
|
-$1.87 M
|
-$5.59 M
|
-$7.70 M
|
-$3.57 M
|
-$357,000.00
|
-$1.06 M
|
$158,000.00
|
-$2.72 M
|
-$835,000.00
|
| Income Before Tax |
$19.36 M
|
-$22.07 M
|
-$21.26 M
|
-$32.26 M
|
$5.15 M
|
$54.90 M
|
$52.41 M
|
$46.01 M
|
$31.56 M
|
$4.42 M
|
| Income Before Tax Ratio |
0.04
|
-0.05
|
-0.04
|
-0.06
|
0.01
|
0.14
|
0.14
|
0.13
|
0.09
|
0.02
|
| Income Tax Expense |
$6.18 M
|
-$5.45 M
|
-$5.59 M
|
-$9.33 M
|
$25.44 M
|
$12.31 M
|
$14.49 M
|
$13.53 M
|
$8.69 M
|
$536,000.00
|
| Net Income |
$13.18 M
|
-$16.61 M
|
-$15.67 M
|
-$22.94 M
|
-$20.29 M
|
$42.59 M
|
$37.92 M
|
$32.48 M
|
$22.88 M
|
$3.88 M
|
| Net Income Ratio |
0.03
|
-0.04
|
-0.03
|
-0.04
|
-0.04
|
0.11
|
0.1
|
0.09
|
0.07
|
0.01
|
| EPS |
0.39 |
-0.49 |
-0.47 |
-0.69 |
-0.62 |
1.31 |
1.17 |
1.03 |
0.76 |
0.13 |
| EPS Diluted |
0.39 |
-0.49 |
-0.47 |
-0.69 |
-0.62 |
1.29 |
1.14 |
1 |
0.74 |
0.13 |
| Weighted Average Shares Out |
$33.97 M
|
$33.56 M
|
$33.70 M
|
$33.11 M
|
$32.56 M
|
$32.46 M
|
$32.35 M
|
$31.50 M
|
$29.99 M
|
$29.03 M
|
| Weighted Average Shares Out Diluted |
$33.97 M
|
$33.56 M
|
$33.70 M
|
$33.11 M
|
$32.56 M
|
$33.06 M
|
$33.24 M
|
$32.57 M
|
$30.82 M
|
$29.84 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
